Cycloechinulin inhibits breast cancer progression via the SGOL2/METTL3/ICAM2 signaling axis and suppresses the growth of breast cancer patient-derived organoids.
- DOI
- 10.1016/j.cellsig.2026.112875
- Published
- 2026 Sep 4
- Container
- Cellular signalling
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.cellsig.2026.112875,
title = {Cycloechinulin inhibits breast cancer progression via the SGOL2/METTL3/ICAM2 signaling axis and suppresses the growth of breast cancer patient-derived organoids.},
author = {Liu S and Zeng B and Chen D and Zhang R and Wang Z and Liu Y and Tang P and Xiao J and He J},
year = {2026},
journal = {Cellular signalling},
doi = {10.1016/j.cellsig.2026.112875},
url = {https://doi.org/10.1016/j.cellsig.2026.112875}
}RIS
TY - JOUR TI - Cycloechinulin inhibits breast cancer progression via the SGOL2/METTL3/ICAM2 signaling axis and suppresses the growth of breast cancer patient-derived organoids. AU - Liu S AU - Zeng B AU - Chen D AU - Zhang R AU - Wang Z AU - Liu Y AU - Tang P AU - Xiao J AU - He J PY - 2026 JO - Cellular signalling DO - 10.1016/j.cellsig.2026.112875 UR - https://doi.org/10.1016/j.cellsig.2026.112875 ER -
APA
S, L., B, Z., D, C., R, Z., Z, W., Y, L., P, T., J, X., & J, H. (2026). Cycloechinulin inhibits breast cancer progression via the SGOL2/METTL3/ICAM2 signaling axis and suppresses the growth of breast cancer patient-derived organoids.. Cellular signalling. https://doi.org/10.1016/j.cellsig.2026.112875
Source records
- pubmed · retrieved 2026-09-25T22:17:19.603Z